The Council of Europe Appoints Petra Dörr as Future EDQM Director

It was announced in a June 28, 2021 press release, that the Council of Europe has appointed Petra Dörr, PhD, as the future director of the European Directorate for the Quality of Medicines and Healthcare (EDQM).

In October 2021, Dörr will take over the role from Susanne Keitel and will bring with her over 25 years of international experience in the pharmaceutical industry—both private and public sectors. Currently, Dörr is the head of Unit Regulation and Prequalification Department, Access to Medicines and Health Products Division at the World Health Organization (WHO). In this role, Dörr heads up teams dealing with facilitated product introduction, incidents and substandard or falsified medical products, laboratory services and networks, pharmacovigilance, regulatory convergence and networks, and regulatory system strengthening.

Early on in her career, after training as a pharmacist, Dörr worked in the medical products industry for a decade in international regulatory affairs. In October 2004, Dörr joined Swissmedic as the head of International Affairs and in July 2007 was promoted to head of Management Services and Networking, and became a member of the management board. Between January 2014 and June 2019, Dörr was the head of Communication and Networking and deputy executive director of Swissmedic.

Additionally, Dörr served as the chair of the International Pharmaceutical Regulators Forum (IPRF)—now known as the International Pharmaceutical Regulators Programme (IPRP)—from 2013 until 2016. She was elected as the vice-chair of the International Council for Harmonisation (ICH) Assembly in November 2018 and has been a member of the ICH Management Committee, the IPRP Management Committee, and represented Swissmedic at the Heads of Agencies Summits/International Coalition of Medicines Regulatory Authorities meetings.

Source: Council of Europe